RIGEL PHARMACEUTICALS INC

For the period ended Dec 31, 2023. Filed Mar 5, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 5, 2024

RIGL$39.65-13.3%Stored close · as of Nov 6, 2026

Opening this filing…